ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BF4RFH31
Stock Name / FundiShares MSCI World Small Cap UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares III Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300PZLRJB7M8H1057
ETF TickerWSML(USD) LSE
ETF TickerWLDS(GBP) LSE
ETF TickerIUSN(EUR) F
ETF TickerIUSN.DE(EUR) CXE
ETF TickerWLDS.LS(GBP) CXE
ETF TickerWSML.LS(USD) CXE
ETF TickerWSML.L(GBP) LSE
ETF TickerWLDS.L(GBP) LSE

Holdings detail for MLAB

Stock NameMesa Laboratories Inc
TickerMLAB(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS59064R1095
LEI549300ZCG738WLX8ZW79

Show aggregate MLAB holdings

News associated with MLAB

Implied VIOO Analyst Target Price: $124
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-19 08:09:35
Choreo LLC Decreases Position in Mesa Laboratories, Inc. (NASDAQ:MLAB)
Choreo LLC lowered its stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 3.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,887 shares of the medical instruments supplier’s stock after selling 165 shares during the quarter. Choreo LLC owned 0.09% […] - 2025-07-28 05:46:54
Bank of New York Mellon Corp Boosts Holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB)
Bank of New York Mellon Corp lifted its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 2.7% during the first quarter, Holdings Channel reports. The institutional investor owned 54,767 shares of the medical instruments supplier’s stock after acquiring an additional 1,463 shares during the quarter. Bank of New York Mellon Corp’s holdings in […] - 2025-07-24 04:20:52
Mesa Laboratories (NASDAQ:MLAB) Downgraded by Wall Street Zen to “Buy”
Wall Street Zen lowered shares of Mesa Laboratories (NASDAQ:MLAB – Free Report) from a strong-buy rating to a buy rating in a research note issued to investors on Friday morning. Separately, Wells Fargo & Company decreased their price target on Mesa Laboratories from $120.00 to $100.00 and set an “underweight” rating on the stock in […] - 2025-06-02 04:20:57
Ameriprise Financial Inc. Acquires 99,819 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB)
Ameriprise Financial Inc. boosted its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 191.8% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 151,862 shares of the medical instruments supplier’s stock after purchasing an additional 99,819 shares during the period. Ameriprise Financial Inc.’s holdings in Mesa Laboratories were worth $20,026,000 as of […] - 2025-05-16 05:01:15
Implied IJT Analyst Target Price: $153
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-15 07:40:17
Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares Sold by Dimensional Fund Advisors LP
Dimensional Fund Advisors LP trimmed its position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 7.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 113,850 shares of the medical instruments supplier’s stock after selling 9,723 shares during the […] - 2025-05-09 05:02:47
Short Interest in Mesa Laboratories, Inc. (NASDAQ:MLAB) Rises By 20.1%
Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report) was the recipient of a large increase in short interest in April. As of April 15th, there was short interest totalling 224,300 shares, an increase of 20.1% from the March 31st total of 186,700 shares. Based on an average trading volume of 44,100 shares, the short-interest ratio […] - 2025-05-05 05:30:49
Mesa Laboratories, Inc. (NASDAQ:MLAB) Stake Decreased by CANADA LIFE ASSURANCE Co
CANADA LIFE ASSURANCE Co reduced its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 7.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,927 shares of the medical instruments supplier’s stock after selling 577 shares during the quarter. […] - 2025-04-30 05:44:12
Analysts Expect SPTM To Hit $83
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-04-02 08:02:55
Choreo LLC Grows Stock Holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB)
Choreo LLC lifted its position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 38.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,052 shares of the medical instruments supplier’s stock after purchasing an additional 1,392 shares during […] - 2025-02-11 06:46:52
Mesa Laboratories (NASDAQ:MLAB) Shares Up 12.3% After Better-Than-Expected Earnings
Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report)’s stock price was up 12.3% during mid-day trading on Tuesday after the company announced better than expected quarterly earnings. The stock traded as high as $143.94 and last traded at $150.43. Approximately 4,303 shares changed hands during trading, a decline of 85% from the average daily volume […] - 2025-02-06 04:08:53
Mesa Laboratories (NASDAQ:MLAB) Hits New 12-Month High After Earnings Beat
Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report)’s stock price reached a new 52-week high on Wednesday following a stronger than expected earnings report. The company traded as high as $152.75 and last traded at $137.27, with a volume of 68479 shares traded. The stock had previously closed at $133.93. The medical instruments supplier reported […] - 2025-02-05 04:40:49

iShares MSCI World Small Cap UCITS ETF USD (Acc) MLAB holdings

DateNumber of MLAB Shares HeldBase Market Value of MLAB SharesLocal Market Value of MLAB SharesChange in MLAB Shares HeldChange in MLAB Base ValueCurrent Price per MLAB Share HeldPrevious Price per MLAB Share Held
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of MLAB by Blackrock for IE00BF4RFH31

Show aggregate share trades of MLAB

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-08-21BUY1366.91069.510 69.250USD 900 114.69
2025-08-15BUY2668.87069.980 69.869USD 1,817 115.13
2025-08-07BUY7863.47066.150 65.882USD 5,139 116.13
2025-07-29BUY2676.78078.000 77.878USD 2,025 117.71
2025-07-14BUY5282.86088.050 87.531USD 4,552 120.25
2025-06-30BUY4894.22098.910 98.441USD 4,725 121.55
2025-06-25BUY7297.990100.590 100.330USD 7,224 121.96
2025-06-20SELL-1395.82096.270 96.225USD -1,251 122.39 Profit of 340 on sale
2025-06-12SELL-10499.890104.410 103.958USD -10,812 123.38 Profit of 2,020 on sale
2025-06-02BUY3997.960101.730 101.353USD 3,953 124.49
2025-05-28BUY26103.070110.870 110.090USD 2,862 124.91
2025-05-14BUY12120.100126.560 125.914USD 1,511 125.58
2025-05-13BUY24126.940129.610 129.343USD 3,104 125.57
2025-05-07BUY36120.290122.190 122.000USD 4,392 125.61
2025-04-28BUY12117.110118.320 118.199USD 1,418 126.05
2025-04-16BUY156112.920115.680 115.404USD 18,003 126.88
2025-04-14BUY24114.090116.510 116.268USD 2,790 127.08
2025-04-08SELL-24105.240115.060 114.078USD -2,738 127.61 Profit of 325 on sale
2025-04-04SELL-26108.000110.370 110.133USD -2,863 127.94 Profit of 463 on sale
2025-03-28BUY120119.570125.000 124.457USD 14,935 128.26
2025-03-12SELL-24123.420128.250 127.767USD -3,066 128.66 Profit of 21 on sale
2025-03-04SELL-24136.240137.470 137.347USD -3,296 128.46 Loss of -213 on sale
2025-02-26SELL-48144.500147.590 147.281USD -7,069 128.01 Loss of -925 on sale
2025-02-13BUY13145.630145.630 145.630USD 1,893 126.06
2025-02-12BUY48142.630149.660 148.957USD 7,150 125.85
2025-01-27BUY12139.490140.500 140.399USD 1,685 123.05
2025-01-23BUY12142.410143.700 143.571USD 1,723 122.50
2025-01-08SELL-84142.030142.040 142.039USD -11,931 118.82 Loss of -1,950 on sale
2024-12-30BUY52132.040133.120 133.012USD 6,917 118.32
2024-12-09BUY468131.060132.430 132.293USD 61,913 117.85
2024-12-04BUY26126.330126.540 126.519USD 3,289 117.43
2024-12-03BUY39123.000123.090 123.081USD 4,800 117.31
2024-11-19BUY7899.750102.070 101.838USD 7,943 119.19
2024-11-18BUY26103.050103.930 103.842USD 2,700 119.68
2024-11-12BUY52112.400119.680 118.952USD 6,186 119.91
2024-11-11BUY13118.940121.000 120.794USD 1,570 119.97
2024-11-11BUY13118.940121.000 120.794USD 1,570 119.97
2024-11-07BUY60117.890133.550 131.984USD 7,919 120.22
2024-11-07BUY60117.890133.550 131.984USD 7,919 120.22
2024-10-23BUY24120.000132.980 131.682USD 3,160 133.65
2024-10-23BUY24120.000132.980 131.682USD 3,160 133.65
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of MLAB

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1950,326068,05274.0%
2025-09-1836,525048,23075.7%
2025-09-1734,714049,66169.9%
2025-09-1634,101065,10052.4%
2025-09-1576,0480143,71952.9%
2025-09-1260,1010101,87159.0%
2025-09-1144,811074,31460.3%
2025-09-1044,12225666,06466.8%
2025-09-0940,070057,00170.3%
2025-09-0860,8490100,07860.8%
2025-09-0521,256044,07648.2%
2025-09-0434,642075,10446.1%
2025-09-0318,550034,66653.5%
2025-09-0214,573029,08950.1%
2025-08-2926,726061,35043.6%
2025-08-2813,200025,93950.9%
2025-08-2711,079017,77362.3%
2025-08-2611,978025,77946.5%
2025-08-2512,753015,62881.6%
2025-08-2224,392036,99665.9%
2025-08-2121,835029,11875.0%
2025-08-2017,748020,40587.0%
2025-08-1916,376020,05681.7%
2025-08-1824,845033,74673.6%
2025-08-1538,699050,73076.3%
2025-08-1428,447041,08769.2%
2025-08-1330,727041,49474.1%
2025-08-1222,059029,87473.8%
2025-08-1133,535044,43975.5%
2025-08-0844,773051,57386.8%
2025-08-0747,023070,94766.3%
2025-08-0666,1382,618116,95256.6%
2025-08-0548,1512,57779,09660.9%
2025-08-0418,085030,00360.3%
2025-08-0132,642144,83472.8%
2025-07-3123,535028,29483.2%
2025-07-3021,088028,52773.9%
2025-07-2913,834020,24168.3%
2025-07-2818,435023,81277.4%
2025-07-2514,516020,18771.9%
2025-07-2432,558042,02777.5%
2025-07-2333,147744,62474.3%
2025-07-2237,85430646,90380.7%
2025-07-2131,176046,12767.6%
2025-07-1833,504056,45959.3%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy